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Objective: To investigate the roles of exogenous basic ﬁbroblast growth factor (bFGF) on the repair of full-
thickness articular cartilage defects in rabbits.
Design: In the present study, a double-layered collagen membrane sandwiched with bFGF-loaded-
nanoparticles between a dense layer and a loose layer was implanted into full-thickness articular
cartilage defects in rabbits. By grafting the membrane in a different direction, the dense layer or the loose
layer facing the surface of the subchondral bone, the effects of the released bFGF on the defects and the
proﬁles of nine growth factors (GFs) in synovial ﬂuid (SF) were investigated using histological methods
and antibody arrays, respectively.
Results: In the group with the loose layer facing the surface of the subchondral bone, fast release of bFGF
was observed, and early high levels of endogenous transforming growth factor-b2 (TGF-b2), vascular
endothelial growth factor (VEGF), bFGF, bone morphogenetic protein 2 (BMP-2), BMP-3, and BMP-4 in SF
were detected by antibody arrays, especially on day 3. Chondrocyte-like cells were also observed in this
group at an early stage. As a result, this group showed better levels of repair, as compared to the other
groups in which low GF levels were detected at an early stage, and chondrocyte-like cells appeared much
later.
Conclusions: Our study suggests that exogenous bFGF promotes articular cartilage repair by up-regulating
the levels of multiple GFs, but administration at an early stage is required.
 2013 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.Introduction
Articular cartilage defects are one of the most challenging issues
in the ﬁeld of regenerative medicine because of their poor intrinsic
repair capacity1e3. In order to overcome the limitations, a large
number of methods have been developed, such as bone marrow
stimulation, osteochondral grafting, autologous chondrocytes im-
plantation (ACI), and implantation of biomaterials3e7. However,
these methods have not always led to satisfactory outcomes8.. Li and Q. Zhang, Institute of
ical Sciences, Peking Union




.com (L. Liu), guanyaman@
Q. Zhang), wanghai907@
s Research Society International. PVarious growth factors (GFs) such as basic ﬁbroblast growth
factor (bFGF), bonemorphogenetic protein 2 (BMP-2), transforming
growth factor-b1 (TGF-b1), and insulin-like growth factor (IGF)
have been introduced to promote cartilage repair8e15. Among these
GFs, bFGF has received considerable attention; however, its role in
cartilage homeostasis and regeneration is contradictory8e12. Pre-
vious studies have suggested that the mitogenic effect of bFGF is a
sign of degeneration rather than regeneration16,17. However, in
various animal experiments, exogenous bFGF accelerated cartilage
repair and subchondral bone formation8e12. In light of these results,
there is a signiﬁcant need to explain the cartilage repair mechanism
of bFGF, and hence develop therapeutic applications for bFGF.
It is recognized that therapeutic efﬁcacy can be enhanced
through the controlled release of GFs from implanted devices18e22.
A large number of methods have been developed to construct GFs
delivery systems using either chemical immobilization or physical
encapsulation of the GFs onto or into various biomaterials18e24.
However, the different methods by which GFs may be delivered
have been shown to induce speciﬁc biological responses, evenublished by Elsevier Ltd. All rights reserved.
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have observed that delivering vascular endothelial growth factor
(VEGF) in a spatial concentration gradient induces the formation of
spatially organized blood vessels. The control group, inwhich VEGF
was not spatially distributed, exhibited less efﬁcacy25. The density
and maturation of newly formed blood vessel were found to be
better when VEGF and platelet-derived growth factor (PDGF) were
sequentially released from a poly (lactide-co-glycolide) scaffold as
compared to when the blood vessels were treated with simulta-
neous delivery of the same factors19,26. Therefore, these different
methods of spatiotemporal delivery for the GFs possibly result in
different repair outcomes. Accordingly, comparison of the under-
lying mechanisms by which repairs are induced by the different
methods of delivery of bFGF will advance our understanding of the
role of exogenous bFGF in cartilage repair.
In this study, we used a previously reported bFGF incorporated
double-layered collagen membrane to repair cartilage defect. The
membrane is composed of a dense layer and a loose layer, and
possesses different release proﬁles from different layer in vitro27.
The membrane was implanted into the full-thickness articular
cartilage defects of the knees of rabbits in different directions. Nine
GFs in the synovial ﬂuids (SFs) of the defective knees were exam-
ined by antibody arrays, and the repair effects were histologically
assessed. By comparing the different bFGF release proﬁles, induced
GF proﬁles, cell phenotypes, and subsequently repair effects in
different groups, we tried to elucidate the mechanism by which
exogenous bFGF acts on cartilage repair.
Methods
Preparation of collagen-based membranes
As previously described by our group, a double-layered collagen
membrane incorporating bFGF-loaded chitosan-heparin (CS-Hep)
nanoparticles was prepared27. Brieﬂy, the bFGF-loaded CS-Hep
nanoparticles were ﬁrst prepared by employing the polyelectrolyte
gelation process. Thereafter, the loose freeze-dried collagen layer
and the dense air-dried collagen layer were prepared and cross-
linked sequentially with D-ribose. The loose layer was wetted and
laid on a ﬂat stainless plate, and then nanoparticle suspension was
dropped slowly on the surface of this layer. This layer was then air-
dried at 4C. Thereafter, the wet-dense layer was laid carefully on
the surface of the loose layer followed by air-drying completely at
4C. The amount of bFGF (recombinant human bFGF, rhbFGF) used
was 100 ng/cm2 of the membrane. Double-layered membranes
without bFGF were also prepared. The size of the membranes was
ca.1.5 cm in diameter and ca.1mm in thickness. Themorphology of
membranes was examined by scanning electron microscope (SEM;
JSM-6700). After ﬁxation with 4% paraformaldehyde solution, the
membranes were embedded in parafﬁn, cut into longitudinal sec-
tions, and then stained with alcian blue-periodic acid Schiff (AB-
PAS) dual staining. The sections were observed and imaged using a
light microscope (Leica DMRB with DFC420Cþ CCD). The mem-
branes were sterilized with gamma irradiation (25 kGy) before
implanting.
Surgical grafting and SF and tissue recovery
All animal experiments were conducted according to the
guidelines provided by the Animal Committee of Tianjin, China.
Forty Japanese white rabbits weighing 2.7e3.5 kg were used after
at least 1 week of accommodation. The animals were anesthetized
by intramuscular administration of 0.2 mg/kg Su-Mian-Xin II
(HuaMu Animal Health Care Products Co, Ltd. Jilin Province, China).
Anesthesia was maintained by intramuscular injection at 30-minintervals of half doses of the above solution during operation.
Both right and left knees were operated on under sterile conditions.
After skin incision, the patella was dislocated laterally. To avoid a
direct inﬂuence by compression during the repair course, the full-
thickness cylindrical defects, 4 mm in diameter and 5 mm deep,
were created at the center of the trochlear groove of the femur
using a trephine. After all the debris was cleaned by ﬂushing with
saline, the implants were transplanted randomly. Both membranes
with and without bFGF were used. All implanted membranes were
cut into wafers with a diameter of ca. 4 mm. They were then placed
at the subchondral bone level such that they clung to the sub-
chondral bone of the defects (Fig. S1). The animals were divided
into ﬁve groups: membranes (1) with and (2) without bFGF with
the loose layer facing the subchondral bone (denoted bl- and l-
layer, respectively); membranes (3) with and (4) without bFGFwith
the dense layer facing the subchondral bone (denoted bd- and d-
layer, respectively); and (5) the control groupwithout any implants.
Finally, the joint capsule, fascial layer, and the skin were closed.
After the operation, all rabbits were allowed to move freely in the
cages without any splints. The animals were euthanized with an
overdose of the anesthetic agent at 1, 2, 4, 8, or 16 weeks after the
operation, and the entire knees (n ¼ 4 in each group) were
dissected. The SFs of three animals from each group were extracted
before they were euthanized randomly at 1, 2, 4, and 8 weeks.
Brieﬂy, 0.5 mL physiological saline solution was injected from the
patella superolaterally, and after passive full knee movements, the
ﬂuid was extracted. The tissues of the animals after 16 weeks of
implantation were retrieved using the same method as described
above, but the SFs were extracted on the third day after the oper-
ation. All the collected SF sample volumes were recorded and the
samples were then stored at 20C until analysis.
Antibody array detection
Nine GFs in SFs were examined using antibody arrays (Table S1).
The collected samples were dialyzed and labeled according to the
amount of total protein detected. The samples were analyzed using
customized RayBio L-Series Human Cytokine Arrays by Ray Biotech,
Inc., according to the manufacturer’s instructions. The antibody
array membranes were imaged in a darkroom by using a chemi-
luminescent imaging system (UVP Darkroom EC3 Imaging System).
For each spot on the array, the net optical intensity level was
determined using the Ray-Bio Antibody Array Analysis Tool (Ray
Biotech). The positive control signal on eachmembranewas used to
normalize the signal intensities of individual spots from different
membranes so that they could be compared.
Macroscopic and histological examination
Restored cartilage was examined for its color, integrity, and
smoothness. After ﬁxation with 4% paraformaldehyde solution,
three random collected tissues of each group at the 1st, 2nd, 4th,
8th, and 16th week were tested by histological observation. Brieﬂy,
the specimens were decalciﬁed using ethylenediaminetetraacetic
acid (EDTA) solution for 7 days and embedded in parafﬁn. Sections
of 4 mm thickness were cut sagittally through the center of the
defect. They were then stained with hematoxylin and eosin (HE) or
AB-PAS, or used for immunohistochemical examination. The sec-
tions were observed and imaged using a light microscope.
Immunohistochemical examination
Sections of collected tissues at the 1st, 8th and 16th week were
stripped of parafﬁn embedding using xylene and then dehydrated
using graded alcohols. For antigen retrieval, the sections were
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and then incubated with 3% H2O2 for 20min to quench endogenous
peroxidase activity. This was followed by treatmentwith phosphate
buffered saline (PBS, pH 7.4) containing 10% normal goat serum,
and incubation at 37C for 20 min in order to block nonspeciﬁc
staining. The sections were then incubated with primary antibodies
(Mouse monoclonal Anti-FGF2 antibody, Santa Cruz; or mouse
monoclonal anti-type II collagen, Thermo Fisher Scientiﬁc) at 4C
overnight. On the following day, a secondary goat anti-mouse IgG
antibody (EarthOx or Thermo Fisher Scientiﬁc) was added at 37C
for 30 min, and immunostained with peroxidase-conjugated
streptavidin and (3, 3’-diaminobenzidine) Substrate Kit, followed
by counterstaining with hematoxylin.
Histological scoring
For semi-quantitative analysis of the repaired tissue, histological
sections from three samples (keens) of each group c taken in the
8th and 16th week were scored according to a modiﬁed version of
the histological grading scale8. Six categories, including cell
morphology, matrix staining, surface regularity, thickness of carti-
lage, regenerated subchondral bone, and integration with adjacent
cartilage, were scored on a scale from 0 to 16 points, with 16 points
referring to normal tissue.
Statistical analyses
Signals detected by antibody arrays with intensities of at least
5% of the positive control signal were considered positive, and re-
ported as a signal ratio: a percentage of the signal of the positive
control. The results data were expressed as the mean  SD. Stu-
dent’s t-test was used to determine the statistical signiﬁcance.
Gaussian distribution and homogenous variance were tested in all
original histological scores, and then the data were analyzed by
general linear model (GLM) univariate with Levene’s Test for
equality of variance and Bonferroni correction in order to verify the
statistical signiﬁcance among various treated groups. All statistical
analyses were performed using SPSS (vision 17) based on statisti-
cally independent observations. Data were expressed as the
means  95% conﬁdence intervals (CI), and differences wereFig. 1. The morphology of the double-layered collagen membrane. (AeC) SEM images and (D
CS-Hep nanoparticles loaded with bFGF. (A) The dense layer; (B) the loose layer; (C) the lo
stained using AB-PAS; (E and F) higher magniﬁcation of D. The blue staining in D and E
bar ¼ 100 mm).considered statistically signiﬁcant when the P-value was less than
0.05.
Results
Characterization of the double-layered collagen membrane
To examine the structure of the double-layered membranes, the
membraneswere examined by SEM andmicroscope. Figure 1(A and
B) shows the typical SEM images of the double-layered membrane,
which consisted of a dense layer [Fig. 1(A)] and a loose layer
[Fig.1(B)]. The outer surface of the loose layerwasmade tighter than
it was originally, but in some areas of the surface, open and inter-
connected pores were observed. In contrast, a dense, ﬂat, and
smooth surface without obvious pores was formed on the dense
layer. The CS-Hep irregular nanoparticles were aligned on the inner
surface of the loose layer before covering thedense layer as shown in
Fig. 1(C). In the AB-PAS-stained sections [Fig. 1(DeF)], blue-stained
particles were observed, which indicated that CS-Hep particles
had been sandwiched between the loose layer and the dense layer.
In vivo release of bFGF from the double-layered membrane
To investigate the in vivo release property, the release behaviors
of bFGF from the membrane were analyzed histologically after
implantation. The membranes retained their integrity and the two
layers remained distinguishable throughout the ﬁrst week (Fig. 2).
The particles were distributed within the layers, as indicated by the
blue staining. Due to the same stained shade as the AB-PAS-positive
particles shown in Fig. 1(DeF), these particles were considered as
aggregated CS-Hep nanoparticles. The arresting thingwas thatmost
blue-stained particles were evenly distributed within the loose
layer [Fig. 2(A and C)], while they were less distributed within the
dense layer [Fig. 2(B and D)]. And these particles within the loose
layers were positive with anti-bFGF immunostaining especially
adjacent to the outer layers, while within the deep layer, although
particles can be observed, no positive signals of rhbFGF can be
identiﬁed. Subsequently, in the following week, the membranes
collapsed and the nanoparticles disappeared, which indirectly in-
dicates that rhbFGF was released or degraded completely (Fig. 3).eF) optical microscope images of the double-layered collagen membrane incorporating
ose layer at a higher magniﬁcation; (DeF) the longitudinal section of the membrane
indicate that there were CS-Hep nanoparticles sandwiched in the membrane (scale
Fig. 2. The release of bFGF, shown in histological images, in the bl-layer group (A and C) and bd-layer group (B and D) at 1 week post-operation. Sagittal sections stained with AB-
PAS. (C) and (D) are the higher magniﬁcations of the corresponding areas marked with rectangles in (A) and (B), respectively. NP indicates the CS-Hep nanoparticles. Bl- and bd-
layer: membrane with bFGF implanted with the loose and dense layer facing the subchondral bone, respectively. EeG, rhbFGF immunostaining, the positive staining were found
mainly distributed within the loose layers especially adjacent to the outer layer (E, F), while within the deep layer, although blue particles can be observed, but no positive signals of
rhbFGF can be identiﬁed (F). And in the groups treated with membranes without bFGF, although blue particles can be observed within the loose layer, no bFGF positive signal can be
identiﬁed (G) (scale bar, AeD, 100 mm; E and F, 10 mm; G, 20 mm).
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To ﬁnd the differences of the proﬁles of the nine GFs, the pro-
teins were detected by antibody array. After the normalization of
the signal intensities, TGF-b2, VEGF, bFGF, BMP-2, BMP-3, and BMP-
4 showed high signal ratios (>5%). However, BMP-7, IGF-1, and TGF-
b1 did not (not shown). Interestingly, all the proteins with high
signal ratios could be detected continually up to 8 weeks [Fig. 4(A)].
More importantly, the abovementioned six proteins could beFig. 3. The histological appearance of regenerated tissues in membrane with bFGF and th
letters, “b,” “c,” and “m” indicate newly formed bone, chondrocyte-like cells, and the collage
the same meaning as in Fig. 2 (scale bar ¼ 100 mm).detected in all groups, therefore, same types of GFs involved in all
groups, no matter membrane-treated or not.
As shown in Fig. 4(A), the six detectable proteins in all groups
showed similar changes within the same group. In order to
compare the changes in protein proﬁles, the signal ratios were
calculated by averaging the median of the signal ratios in the same
group. Different changing proﬁles and peak ratios among the
groups are shown in Fig. 4(B). The peak ratio (ca. 63%) of the control
group appeared after the 1st week; while a peak ratio (ca. 49%) ofe control at 2 and 4 weeks post-operation, sagittal sections stained with AB-PAS. The
n membrane, respectively. Control: without treatment; bl-layer and bd-layer represent
Fig. 4. The signal ratios of the GFs in SFs as percentages of the positive control on antibody arrays. (A) The signal ratios of VEGF, TGFb2, bFGF, BMP-2, BMP-3, and BMP-4 on days, 1, 2,
3, 4, and 8 weeks post-operatively. The positive control was 100%. n ¼ 3, mean  SD. (B) The gross post-operative changes of the six proteins of all groups, by ﬁtting all signal ratios
of the detectable proteins through averaging the median of the signal ratios in the same group. Control, bl-, and bd-layer represent the same meaning as in Fig. 3; l- and d-layer:
membrane without bFGF implanted with the loose and dense layer facing the subchondral bone, respectively.
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lower peak ratio (ca. 34%) for the bd-layer group was observed at
the second week, and no obvious peak ratios appeared in the other
two groups. Notably, the ratios of all the membrane-treated groups
were slightly higher in the second week.
Macroscopic observation of the repair tissues
To compare the effectiveness among groups on cartilage repair,
all the collected tissue samples were observed macroscopically at
preset times. Therewere no obvious differences among the bl-, bd-,
l-, and d-layer groups [Fig. S3(BeE)], and the defects were ﬁlled by
opaque materials at the ﬁrst week after operation. Thereafter, the
membranes digested obviously, and only thinner covers and pieces
of the membranes remained in these groups after 2 weeks[Fig. S3(GeJ)]. The repair tissues appeared different after 4 weeks
among the four membrane-treated groups: in both bl- and l-layer
groups, the defects were near capacity, while in the other groups,
the defects were identiﬁable [Fig. S3(LeO)]. By the 8th and 16th
week, the differences were distinguishable. The restored tissues in
the l- and bl-layer groups appeared glossy and smooth, and were
similar in color to neighboring normal cartilage [Fig. S3(Q, R, V and
W)]. The margins were blurred, although part of the repaired tis-
sues in the l-layer group was whitish and rough [Fig. S3(R and W)].
The newly formed tissues in the d- and bd-layer groups appeared
irregular, concave, white, opaque, and distinguishable from the
normal cartilage [Fig. S3(S, T, X and Y)].
In contrast, in the control group, reddish granulated tissue
appeared in the ﬁrst and second week; ﬁnally, at the 16th week
after their operation, the defects ﬁlled with irregularly shaped
X. Li et al. / Osteoarthritis and Cartilage 21 (2013) 1567e15751572whitish repaired tissues with concaves and distinguishable margin
from the normal cartilage [Fig. S3(A, F, P and U)].
Histological observations
Fatherly, the effectiveness of exogenous bFGF on tissues repair
was examined histologically and compared among groups at preset
times. The relative repair effects in all the groups were assessed,
and the performances of the l- and d-layer groups are presented in
the supporting information (Fig. S4).
In Fig. 3, a larger number of inhomogeneous cells in the defects
were observed. Both spindle-shaped and polygon-shaped cells
appeared at the center of the defects 2 weeks post-operation. The
most important ﬁnding was that AB-PAS-positive, spherical
chondrocyte-like cells appeared in both the center and periphery of
the renewed tissues with reddish-blue-stained extracellular
matrices which indicated that sulfated glycosaminoglycan (GAG)
synthesized by the chondrocytes in the bl-layer group in the second
week. These cells persisted in the fourth week and were observed
adjacent to the newly formed bone [Fig. 3(B and E)]. Spherical
chondrocyte-like cells were not found in the bd-layer group until
the fourth week, where they were observed within irregular,
repaired tissue [Fig. 3(C and F)]. However, in the control group, the
articular surfaces were covered with ﬁbrous tissue 2 weeks post-
injury, and no subchondral bone was well reconstituted until 4
weeks [Fig. 3(A and D)].
Thereafter, the reparative process improved with reduced cells
numbers 8 weeks after operation in all the groups. The repaired
tissues in both the bl- and bd-layer groups were thicker than the
normal periphery tissues (Fig. 5). In the bl-layer group, a well-
developed regenerated hyaline articular cartilage appeared with
an orderly vertical columnar arrangement of chondrocytes, with a
regular surface, and integrated well with the normal cartilage and
new bone. The matrices of the bl-layer groups were stained
reddish-blue or bluish-red [Fig. 5(B and E)]. However, in the bd-
layer group, cells in the irregular, repaired tissue areas were
mostly non-chondrocytes and the matrices did not stain with AB-
PAS after 8 weeks, although new subchondral bone did form
[Fig. 5(C and F)]. The defects in the control group were ﬁlled with
thin ﬁbrous tissue [Fig. 5(A and D)].
After 16 weeks, the thickness of repaired tissue decreased in all
the membrane-treated groups (Fig. 6). Although the appearance of
the restored tissue improved, the surfaces in the center remained
irregular in the bd-layer group. Mostly non-chondrocytes occupied
the center of the defects, while chondrocytes appeared at theFig. 5. The histological appearance of regenerated tissues in membrane with bFGF-treated g
and AB-PAS (DeF). Control, bl-layer, and bd-layer represent the same meaning as in Fig. S3
images, unless labeled, display the center of the restored tissues (scale bar ¼ 100 mm).periphery, and the matrices and type II collagen were stained
discontinuously or faintly by AB-PAS dual staining and anti-type II
collagen immunostaining [Fig. 6(C, F, and I)]. Interestingly, with the
reduction in chondrocyte numbers, the regenerated cartilage in the
bl-layer group showed a hyaline-like appearance with surface
regularity, integration with normal cartilage, and the typical carti-
lage lacuna. There was also an abundance of cartilage matrices that
were stained reddish-blue by AB-PAS dual staining, and were
diffusely positive for type II collagen immunostaining [Fig. 6(B, E,
and H)]. The defects in the control group were still ﬁlled with
ﬁbrous tissue in the center [Fig. 6(A, D, and G)].
Histological scores
To quantify the repair outcomes of all groups, the histological
sections in the 8th and 16th week were scored, and the results are
presented in Fig. 7. By the 8 week, the bl-layer group showed the
highest score [Fig. 7(A)]; on the other hand, interestingly, the score
was signiﬁcantly higher in the l-layer group than in the d-layer
group. At the 16th week, the highest score was still observed for the
bl-layer group, while the signiﬁcant difference between the l-layer
group and the d-layer group disappeared [Fig. 7(B)]. There was no
difference in the scores between the bd-layer group and the l-layer
group. Furthermore, at a signiﬁcance level of 0.05, the interaction
between the structures and bFGF was found to be signiﬁcant at the
8th week (P ¼ 0.001), while the interaction was not signiﬁcant
different at the 16th week (P ¼ 0.141), which means that although
both the structure of the layer and bFGF played pivotal roles in
cartilage repair, the synergism between bFGF and the structure only
appeared at early period.
Discussion
To achieve different release proﬁles from different layers of the
double-layered collagen membrane, we sandwiched the bFGF-
incorporated-CS-Hep-nanoparticles between a dense layer and a
loose layer. The average release rate of model protein from the loose
layer to the dense layer was lower than that from the dense layer to
the loose layer27 as summarized in Fig. S1. To investigate the in vivo
release properties, the membrane was implanted in vivo, and then,
the bFGF release behaviors from the membrane were analyzed
histologically. A comparison of the histological images (Fig. 2) with
the in vitro release proﬁles (Fig. S1) suggests that diffusion is still
the main factor in determining the in vivo release proﬁles in the
ﬁrst week, because the membranes did not undergo any obviousroups and control at 8 weeks post-operatively, sagittal sections stained with HE (AeC)
. The letters h and r indicate the host tissues and restored tissues, respectively. Other
Fig. 6. The histological appearance of regenerated tissues in membrane with bFGF and the control at 16-week post-operation, sagittal sections stained with HE (AeC) and AB-PAS
(DeF), and immunohistochemical staining for type II collagen (GeI). Control, bl-, and bd-layer represent the same meaning as in Fig. 3. The letters h and r indicate the host tissues
and restored tissues, respectively. Other images unless labeled, display the center of the restored tissues (scale bar ¼ 100 mm).
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distributed within the loose layer were more than that within the
dense layer, which indicated the particles diffused more easily from
the loose layer than from the dense layer (Fig. 2). Meanwhile,
within the loose layers, anti-bFGF positive staining can be identi-
ﬁed, therefore, it is reasonable to speculate that in vivo, bFGF was
released at different release ratio from the different layers during
the ﬁrst week (Fig. S2). Subsequently, bFGF was burst-released and/
or degraded due to the collapse of the membranes and the nano-
particles disappearing in the second week (Fig. 3). These results
indicated that the release of bFGF was faster in vivo (2 week) than
the in vitro (more than 20 days) due to the membrane degradation.
It is well known that bFGF has been widely used to promote
tissue repair, such as skin28, bone18, and cartilage8e12. Especially,Fig. 7. Histological scoring of the repaired tissue of different groups at (A) 8 and (B) 16 we
<0.001, ¼0.008, <0.001, ¼0.011; n ¼ 3, means  95% CI. Control, bl-, bd-, l-, and d-layer habFGF is known as a chondrocyte mitogen that can stimulate
chondrocytes to synthesize cartilaginous matrix8e12. Moreover,
cartilage regeneration is regulated by the interaction of cytokines,
chemokines, and GFs29, and thorough determination of the proﬁles
of these factors is helpful to fully understand the repairing process
of cartilage30 by detecting the changes of biomolecules in SF31.
In this study, six endogenous GFs, including TGF-b2, VEGF, bFGF,
BMP-2, BMP-3, and BMP-4 were positive. These proteins were
believed to have positive effects on cartilage repair8e15, and were
detectable in SFs of injured cartilage32e34. While the weak signals
of BMP-7, IGF-1, and TGF-b1 may be due to the lack of special cross-
reactivates with the antibodies on the arrays, and they are also
identiﬁed as promoting factors. However, it should be noted,
Schmal et al. showed that the amount of BMP-7 did not change aftereks. Asterisks mean signiﬁcant discrepancy, the P value from left to right was <0.001,
ve the same meaning as in Fig. 4.
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may be attributed to the sources of samples, low diffusion levels of
IGF-1 and TGF-b1 into SF. Bos et al. found that TGF-b1 expression in
the cartilage was primarily observed intracellularly35. It was later
reported that IGF-1 is stored within the extracellular matrix of
cartilage where it is bound to proteoglycans, cell surface-located
syndecans, and the IGF-1-binding proteins36,37.
Although there was no signiﬁcant difference in the signal ratio
of each factor for the same point in time, it should be noted that the
membranes could prevent the proteins from diffusing into the
SF, especially during the ﬁrst week. Here, we assumed that the
membranes without bFGF induced the same protein proﬁles as that
observed in the control group. We then calculated that more than
30% of the factors were absorbed or blocked by the membranes on
the third day, and 40% in the ﬁrst week. Adding these partial of the
GFs that were absorbed or blocked by the membranes, the theo-
retical signals of the groups treated by membranes with bFGF were
higher (>30%) than the detected data by antibody array in the ﬁrst
week. As shown in Fig. 4(B), the proﬁles and peak ratios were
different between the bl- and bd-layer groups, therefore the
different release proﬁles of bFGF as determined by the implanted
directions of the double-layered membranes resulted in different
biomolecular responses. Subsequently, the slightly raised signal
ratios in the second week of all the membrane-treated groups
[Fig. 4(B)] were explained by the fact that the proteins absorbed or
blocked by the membranes were released into the SF due to
membrane degradation (Fig. 3). Furthermore, these six endogenous
GFs of the bl-layer group peaked on day 3, suggesting that an early,
fast release of bFGF applied directly to the defects induced the early
high level of these proteins. Collectively, these results suggest that
exogenous bFGF can up-regulate the proﬁles of multiple GFs during
articular cartilage repair.
Although collagen5,38e40 and bFGF8e12 are widely used in
cartilage repair, we found that differences in the implanting di-
rection of the bFGF-loaded collagen membrane induced different
in vivo bFGF release proﬁles that subsequently resulted in different
biomolecular responses. Exogenous bFGF was observed to up-
regulate the levels of multiple GFs during cartilage repair. The
early, fast release of bFGF can induce early GFs that are up-
regulated to create a favorable microenvironment, and which
then induce chondrocyte-like cells to appear at an early stage and
thus deliver the best reparative effects. In contrast, the released
bFGF in the group implanted in the opposite direction achieved no
better reparative outcome than did the groups treated by mem-
branes without bFGF.
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